Cubist Systematic Strategies’s Enzo Biochem, Inc. ENZ Stock Holding History

Cubist Systematic Strategies’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-19,985	Closed	-$48.6K	–	4427
2023 Q1	$48.6K	Buy	+19,985	New	+$29.7K	﹤0.01%	3566
2019 Q3	–	Sell	-7,606	Closed	-$26K	–	2536
2019 Q2	$26K	Buy	+7,606	New	+$26.8K	﹤0.01%	2374
2017 Q3	–	Sell	-11,210	Closed	-$124K	–	2035
2017 Q2	$124K	Buy	+11,210	New	+$104K	0.01%	1415
2016 Q3	–	Sell	-18,529	Closed	-$111K	–	1907
2016 Q2	$111K	Buy	+18,529	New	+$103K	0.01%	1489
2015 Q1	–	Sell	-15,150	Closed	-$67K	–	2109
2014 Q4	$67K	Sell	15,150 -1,896	-11%	-$9.04K	﹤0.01%	1751
2014 Q3	$88K	Buy	+17,046	New	+$90.9K	0.01%	1561

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PCM

Potomac Capital Management New York $115M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cubist Systematic Strategies's ENZ Position: Q2 2023 in Review

Cubist Systematic Strategies sold out of Enzo Biochem, Inc. (ENZ) in Q2 2023, closing a stake of 19,985 shares — an estimated $48.6K sold.

Cubist Systematic Strategies first reported a position in ENZ in Q3 2014 and held it in 6 quarters. The position peaked at $124K in Q2 2017. 47 funds tracked by Wall St. Rank hold ENZ as of Q2 2023.

Cubist Systematic Strategies reported no remaining Enzo Biochem, Inc. position as of Q2 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 19,985 Enzo Biochem, Inc. shares in Q2 2023, an estimated $48.6K.
Cubist Systematic Strategies first reported a position in Enzo Biochem, Inc. in Q3 2014 and held it in 6 quarters.
Cubist Systematic Strategies's Enzo Biochem, Inc. position peaked at $124K in Q2 2017.
47 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2023.

Based on Cubist Systematic Strategies's 13F filing for Q2 2023, filed 14 Aug 2023.